  Metabolic homeostasis is critical to cellular and organismal health. The newly revealed crystal structures of the endocrine factors FGF21 and FGF23 , in association with the glycosidase coreceptor Klotho and transmembrane tyrosine kinase FGFR , set a platform for structure-based novel drug design against common metabolic disorders.